Last edition
News about "adalimumab-adbm"
Boehringer Ingelheim Teams Up with Quallent to Expand Access to adalimumab-adbm Injection
Boehringer Ingelheim has signed a deal with Quallent Pharmaceuticals to help expand patient access to citrate-free adalimumab-adbm, Boehringer's biosimilar to Humira (adalimumab), in the US.
Adalimumab-adbm | 14/05/2024 | By Aishwarya | 219
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members